Jane Street Group, LLC Nautilus Biotechnology, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 37,682 shares of NAUT stock, worth $66,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,682

Previous 62,702 39.9%

Holding current value

$66,320

Previous $146,000 26.71%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.24 - $3.08 $56,044 - $77,061	-25,020 Reduced 39.9%	37,682 $107,000
Q2 2024 Aug 14, 2024	BUY	$2.22 - $3.0 $70,922 - $95,841	31,947 Added 103.88%	62,702 $146,000
Q1 2024 May 15, 2024	SELL	$2.41 - $3.18 $52,858 - $69,746	-21,933 Reduced 41.63%	30,755 $90,000
Q4 2023 Feb 14, 2024	BUY	$2.34 - $3.39 $93,108 - $134,888	39,790 Added 308.5%	52,688 $157,000
Q3 2023 Nov 14, 2023	SELL	$2.87 - $3.94 $29,741 - $40,830	-10,363 Reduced 44.55%	12,898 $40,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.52 $22,517 - $46,054	-10,189 Reduced 30.46%	23,261 $90,000
Q1 2023 May 15, 2023	BUY	$1.67 - $2.77 $55,861 - $92,656	33,450 New	33,450 $92,000
Q2 2022 Aug 16, 2022	SELL	$2.64 - $4.84 $43,401 - $79,569	-16,440 Reduced 56.89%	12,459 $34,000
Q1 2022 May 17, 2022	BUY	$3.5 - $5.3 $57,596 - $87,216	16,456 Added 132.25%	28,899 $125,000
Q4 2021 Feb 15, 2022	SELL	$4.45 - $6.21 $2,296 - $3,204	-516 Reduced 3.98%	12,443 $65,000
Q3 2021 Nov 16, 2021	SELL	$6.14 - $10.1 $986,962 - $1.62 Million	-160,743 Reduced 92.54%	12,959 $80,000
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $1.57 Million - $2.46 Million	173,702 New	173,702 $1.75 Million

Others Institutions Holding NAUT

# of Institutions

Shares Held

64.3M

Call Options Held

1.9K

Put Options Held

100

View Full List

About Nautilus Biotechnology, Inc.

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $219M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

More about NAUT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Nautilus Biotechnology, Inc. Transaction History